about
The predictive power of brain mRNA mappings for in vivo protein density: a positron emission tomography correlation studyThe medial forebrain bundle as a deep brain stimulation target for treatment resistant depression: A review of published data.The relationship between reward and punishment processing and the 5-HT1A receptor as shown by PET.Dopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain.Grey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studies.Serotonin and dopamine play complementary roles in gambling to recover losses.5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.Brain serotonin transporter binding in former users of MDMA ('ecstasy').Presynaptic 5-HT1A is related to 5-HTT receptor density in the human brain.Computational meta-analysis of statistical parametric maps in major depression.Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartateFrom the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairmentsNormal glutamate but elevated myo-inositol in anterior cingulate cortex in recovered depressed patients.Presynaptic Serotoninergic Regulation of Emotional Processing: A Multimodal Brain Imaging Study.Is clinical intervention in the ultra high risk phase effective?Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies.The practical management of refractory schizophrenia--the Maudsley Treatment REview and Assessment Team service approach.Quantification of ligand PET studies using a reference region with a displaceable fraction: application to occupancy studies with [(11)C]-DASB as an example.Dopamine transporter imaging: nonindependence of regional measures.Short-term antidepressant treatment modulates amygdala response to happy faces.Effect of Citalopram on Emotion Processing in Humans: A Combined 5-HT1A [11C]CUMI-101 PET and Functional MRI Study.Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls.Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy.Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [(11)C]PBR28 study.Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB.Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study.Tryptophan depletion does not lower brain GABA levels in healthy volunteers.Increased neural response to fear in patients recovered from depression: a 3T functional magnetic resonance imaging study.The effect of ageing on grey and white matter reductions in schizophrenia.The effects of serotonin modulation on medial prefrontal connectivity strength and stability: A pharmacological fMRI study with citalopram.Human 5-HT transporter availability predicts amygdala reactivity in vivo.Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.Erythropoietin has no effect on hippocampal response during memory retrieval 3 days post-administration.Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.GABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse modelsDecreased regional gray matter volume in S’ allele carriers of the 5-HTTLPR triallelic polymorphismRole of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studiesEffects of citalopram on serotonin neurotransmission
P50
Q23992160-59E73603-5F3D-4693-9896-AC3F8D1D4A47Q30881365-9855B0A8-355B-4AE7-BA15-3602DBCF267AQ33755322-C3ECDD38-2AA9-48B1-B488-FBB4DE6CE579Q34068906-89499BF1-65FB-46AA-BFCE-408515CE4F3FQ34111111-A6AB2E91-CC75-483F-89B0-8EABB8463D7FQ34196913-8AC346CE-D196-4539-956D-2644FC1D0352Q34661794-73BB1FFC-AE76-4FE1-88B9-D3D1EE13767BQ34721207-F5EC4A86-75AA-4A14-8196-1BED184D37BCQ34972448-F9AC3BA6-E951-4EB3-A0D5-728CE6515C40Q35222777-CF625D95-8AED-4A5D-A9C9-A4D7C4FD1A3CQ35917018-61FDC7D4-3C1D-4220-ABC8-97F0E34ABCE2Q36370593-1C5D1783-21F3-4016-8C8F-0279331B108DQ36393298-20F05C39-C2B9-4083-BA8D-9FED47715D30Q36872150-3718E216-3BF8-4EA5-B074-0B50EA74C832Q37407063-A597B2D0-8A3D-4078-B8D8-192DB2C6FA7CQ37661822-C2184C14-B344-4FB1-9CA3-47528AA2230AQ37979672-245EB8E9-FAE9-439A-B9F5-23B825F8998BQ38223822-4B683B24-3CF7-47CE-9078-9CFF157B6DB4Q38247122-6A358FEF-8115-4C0E-A054-B63EFF639AC6Q42551283-7DA76351-DE53-48AA-ADDB-8A5FD8AEB3FAQ42740877-E0AC38FE-3F7A-49D3-AA11-1105806BBF05Q45936088-4957620A-B018-4140-B7C4-D807342534F8Q46526889-6482331C-9FF1-4F08-BA46-1DB0B7F5B9DBQ46597604-D88540CB-DB41-4A8C-87CF-F5A8C4009ABBQ46798756-E363EE82-9F48-4BC5-AE5C-B2F54744514CQ48118494-C69162CC-DC16-4EA4-9193-6458874FE32EQ48458635-98954A99-60BC-4F62-8327-7784FCC8ED19Q48483797-DFBA947B-DD61-4B6D-ADA6-CC192DA5180BQ48500716-F1469504-A3A1-4D64-A6F0-69066F444A72Q48509839-9D81C46E-5FB0-4788-A9A7-CBECCB4FE627Q48610556-06F2670D-2966-47FF-B0BB-6E91B173E9CDQ50152811-16CA35EB-BC0C-4D04-BC5A-9BA70E4621ACQ50890537-630BB6F2-A964-471E-B616-4E164A63A2F4Q50902090-F45D14FE-3C25-4B88-AA5C-5A8783105562Q51900563-EFC78601-2EAF-438C-B4D6-E9BFDA99EE65Q51971879-0D0C71EA-41FE-4606-9493-BF077288DE57Q56964783-7228B22B-9EA6-469A-90AC-27732D06B8DBQ57715345-C831F1AD-9438-4CCC-878D-45E6DB949852Q60062706-ADB5BD60-0B2C-4BE9-A911-DC07F6FBDA5CQ60062708-788483ED-4E71-45C6-8840-DB89ADC8A290
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Sudhakar Selvaraj
@ast
Sudhakar Selvaraj
@en
Sudhakar Selvaraj
@es
Sudhakar Selvaraj
@nl
Sudhakar Selvaraj
@sl
type
label
Sudhakar Selvaraj
@ast
Sudhakar Selvaraj
@en
Sudhakar Selvaraj
@es
Sudhakar Selvaraj
@nl
Sudhakar Selvaraj
@sl
prefLabel
Sudhakar Selvaraj
@ast
Sudhakar Selvaraj
@en
Sudhakar Selvaraj
@es
Sudhakar Selvaraj
@nl
Sudhakar Selvaraj
@sl
P1053
J-4295-2014
P106
P1153
23009994600
P21
P214
5272149235102376690006
P31
P3829
P496
0000-0002-9494-172X
P734
P7859
viaf-5272149235102376690006